New York, NY, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (“Semper Paratus”...
The pro forma equity value of the portion of the combined company attributable to Tevogen Bio Inc (“Tevogen...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.